SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on December 30, 2014, regarding a second closing of a Unit Purchase Agreement dated December 19, 2014. The company is incorporated in Delaware and headquartered in Los Angeles, California.
Key Financial Metrics
The filing details a capital raise event rather than operational financial performance. No revenue, profit, cash flow, margins, or debt metrics are provided in this document.
- Capital Raised (Second Closing): $172,600
- Capital Raised (First Closing): $339,500
- Total Capital Raised (Both Closings): $512,100
- Shares Issued (Second Closing): 69,040 shares of Common Stock
- Shares Issued (First Closing): 135,800 shares of Common Stock
Material Changes
The primary material change is the issuance of unregistered equity securities to accredited investors. On December 30, 2014, the company issued 1.726 units consisting of common stock and warrants to additional investors. This follows a first closing on December 19, 2014, which issued 3.395 units to initial investors.
Guidance, Outlook, and Risks
The filing contains no management guidance, outlook, or discussion of operational risks. The transaction was executed under Section 4(a)(2) and Regulation D (Rule 506) exemptions from registration. The full text of the Purchase Agreement, Investor Warrants, and Registration Rights Agreement is referenced as an exhibit to the upcoming Form 10-K for the fiscal year ended December 31, 2014.
Investor Verification Checklist
- Verify the total number of outstanding shares post-issuance (204,840 shares issued in this round).
- Confirm the exercise prices and expiration dates for the "A" Warrants ($2.50) and "B" Warrants ($3.75).
- Review the Registration Rights Agreement to understand future liquidity options for these investors.
- Check the subsequent Form 10-K for the full legal text of the agreements and updated capitalization table.